Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
June 1, 2024Journal of Clinical Oncology

Trastuzumab, pertuzumab and nab-paclitaxel plus pyrotinib or not in neoadjuvant treatment of HER2-positive breast cancer: A multi-center, randomized, open-label, phase II study.

View Full Paper
Ask AI
Bookmark
Share

Authors

XCXiaosong ChenJHJiahui HuangYTYiwei Tong

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chen et al. (2024) studied this question.

synapsesocial.com/papers/68e67054b6db6435875fa7e6https://doi.org/10.1200/jco.2024.42.16_suppl.e12634
View Full Paper
Ask AI
Bookmark
Share